Related Experiment Video
Updated: Nov 15, 2025

Understanding the Changes in Mitochondrial Morphology through Dynamic and Three-dimensional Fluorescence Micrographs
Published on: August 15, 2025
The Role of Posttranslational Modification and Mitochondrial Quality Control in Cardiovascular Diseases
Jinlin Liu1, Li Zhong1,2, Rui Guo1
1College of Life Sciences, Institute of Life Science and Green Development, Hebei University, Baoding 071002, China.
Insights
Cardiovascular diseases (CVDs) are linked to mitochondrial dysfunction. This review explores how posttranslational modifications (PTMs) impact mitochondrial quality control, offering insights into CVD mechanisms and potential treatments.
Area of Science:
- Biochemistry
- Molecular Biology
- Cardiology
Background:
- Cardiovascular disease (CVD) remains the leading global cause of mortality.
- The precise pathogenesis of CVDs is still debated despite extensive research.
- Mitochondrial homeostasis is crucial for cardiovascular system function.
Purpose of the Study:
- To review the role of posttranslational modifications (PTMs) in regulating mitochondrial quality control.
- To explore how PTMs influence the development of cardiovascular diseases (CVDs).
- To provide insights into potential therapeutic strategies for CVDs.
Main Methods:
- Literature review of common and novel posttranslational modifications (PTMs).
- Analysis of PTMs' impact on mitochondrial quality control mechanisms.
- Synthesis of current understanding of PTMs in cardiovascular disease (CVD) pathogenesis.
Main Results:
- Alterations in mitochondrial protein function can lead to dysfunction and CVDs.
- Posttranslational modifications (PTMs) reversibly alter protein conformation and function.
- Specific PTMs are implicated in regulating mitochondrial quality control pathways relevant to CVDs.
Conclusions:
- Posttranslational modifications (PTMs) are critical regulators of mitochondrial quality control in the context of cardiovascular disease (CVD).
- Understanding PTMs offers new avenues for investigating CVD mechanisms.
- Targeting PTMs presents potential therapeutic opportunities for cardiovascular diseases (CVDs).
Abstract:
Cardiovascular disease (CVD) is the leading cause of death in the world. The mechanism behind CVDs has been studied for decades; however, the pathogenesis is still controversial. Mitochondrial homeostasis plays an essential role in maintaining the normal function of the cardiovascular system. The alterations of any protein function in mitochondria may induce abnormal mitochondrial quality control and unexpected mitochondrial dysfunction, leading to CVDs. Posttranslational modifications (PTMs) affect protein function by reversibly changing their conformation. This review summarizes how common and novel PTMs influence the development of CVDs by regulating mitochondrial quality control. It provides not only ideas for future research on the mechanism of some types of CVDs but also ideas for CVD treatments with therapeutic potential.
Related Concept Videos
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Mitochondria
Mitochondrial Membranes
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Mitochondrial Protein Sorting
Most of these mitochondrial proteins are encoded by the nucleus and imported to the mitochondria as unfolded or loosely folded precursors. Mitochondrial precursors...
Mitochondrial Precursor Proteins
Most of the mitochondrial...

